These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26480931)

  • 1. High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
    Wei Y; Ji XB; Wang YW; Wang JX; Yang EQ; Wang ZC; Sang YQ; Bi ZM; Ren CA; Zhou F; Liu GQ; Peng J; Hou M
    Blood; 2016 Jan; 127(3):296-302; quiz 370. PubMed ID: 26480931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial.
    Yu Y; Wang M; Hou Y; Qin P; Zeng Q; Yu W; Guo X; Wang J; Wang X; Liu G; Chu X; Yang L; Feng Y; Zhou F; Sun Z; Zhang M; Wang X; Wang Z; Ran X; Zhao H; Wang L; Zhang H; Bi K; Li D; Yuan C; Xu R; Wang Y; Zhou Y; Peng J; Liu XG; Hou M
    Am J Hematol; 2020 Dec; 95(12):1542-1552. PubMed ID: 32871029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.
    Mazzucconi MG; Rodeghiero F; Avvisati G; De Stefano V; Gugliotta L; Ruggeri M; Vianelli N; Fazi P; Paoloni F; Sargentini V; Baldacci E; Ferretti A; Martino B; Vincelli ID; Carli G; Fortuna S; Di Ianni M; Ranalli P; Palandri F; Polverelli N; Lugli E; Rivolti E; Patriarca A; Rago A; D'Adda M; Gentile M; Siragusa S; Sibilla S; Carella AM; Rossi E; Battistini R; Zaja F; Bocchia M; Di Renzo N; Musto P; Crugnola M; Giuffrida AC; Krampera M; Tafuri A; Santoro C
    Blood Adv; 2024 Mar; 8(6):1529-1540. PubMed ID: 38231017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of high-dose dexamethasone with or without low-dose dexamethasone maintenance in untreated immune thrombocytopenia.
    Din B; Wang X; Shi Y; Li Y
    Acta Haematol; 2015; 133(1):124-8. PubMed ID: 25247485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First line treatment of adult patients with primary immune thrombocytopenia: a real-world study.
    Wang L; Xu L; Hao H; Jansen AJG; Liu G; Li H; Liu X; Zhao Y; Peng J; Hou M
    Platelets; 2020; 31(1):55-61. PubMed ID: 30744465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy and safety of 2 cycles' high-dose dexamethasone treatment adult primary immune thrombocytopenia].
    Cui ZG; Wei Y; Hou M; Zhao HG; Wang HY
    Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):401-3. PubMed ID: 21624223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience.
    Mazzucconi MG; Fazi P; Bernasconi S; De Rossi G; Leone G; Gugliotta L; Vianelli N; Avvisati G; Rodeghiero F; Amendola A; Baronci C; Carbone C; Quattrin S; Fioritoni G; D'Alfonso G; Mandelli F;
    Blood; 2007 Feb; 109(4):1401-7. PubMed ID: 17077333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of high-dose dexamethasone with sequential prednisone maintenance therapy for newly diagnosed adult immune thrombocytopenia in a real-world setting.
    Xu J; Zhang X; Feng S; Zhao N; Hu X; Cheng Y; Wu Y; Zhou L; Tong J; Zheng C
    J Int Med Res; 2021 Apr; 49(4):3000605211007322. PubMed ID: 33840249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Short term high-dose dexamethasone therapy in previously untreated idiopathic thrombocytopenic purpura].
    Li YF; Liu DS; Ding BH; Zhu JB; Chen BA
    Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):734-6. PubMed ID: 20079208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of treatment plan by three-period pulses of high-dose dexamethasone among patients with primary immune thrombocytopenia on platelet count response and adverse events: A randomized Clinical trial.
    Sadeghi A; Hosseini SF; Jouzdani SR
    J Res Med Sci; 2020; 25():88. PubMed ID: 33273933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study.
    Matschke J; Müller-Beissenhirtz H; Novotny J; Vester I; Hertenstein B; Eisele L; Lax H; Ose C; Dührsen U
    Acta Haematol; 2016; 136(2):101-7. PubMed ID: 27189086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia.
    Feng Q; Xu M; Yu YY; Hou Y; Mi X; Sun YX; Ma S; Zuo XY; Shao LL; Hou M; Zhang XH; Peng J
    J Thromb Haemost; 2017 Sep; 15(9):1845-1858. PubMed ID: 28682499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis.
    Mithoowani S; Gregory-Miller K; Goy J; Miller MC; Wang G; Noroozi N; Kelton JG; Arnold DM
    Lancet Haematol; 2016 Oct; 3(10):e489-e496. PubMed ID: 27658982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between platelet glycoprotein-specific antibodies and response to short-term high-dose dexamethasone with prednisone maintenance treatment in adult patients with primary immune thrombocytopenia.
    Hou YQ; Wang Y; Liu CX; Li SX; Peng YL; Dong-Dong W; Sa RL
    Ann Med; 2022 Dec; 54(1):132-137. PubMed ID: 36799363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients.
    Ishiyama M; Shiseki M; Yoshinaga K; Ryuzaki M; Izuka Y; Watanabe A; Tanaka N; Shinohara A; Hagiwara S; Tanaka J
    Acta Haematol; 2022; 145(2):193-200. PubMed ID: 34818223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsed high-dose dexamethasone modulates Th1-/Th2-chemokine imbalance in immune thrombocytopenia.
    Liu Z; Wang M; Zhou S; Ma J; Shi Y; Peng J; Hou M; Guo C
    J Transl Med; 2016 Oct; 14(1):301. PubMed ID: 27776524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients.
    Ding B; Liu L; Li M; Song X; Zhang Y; Xia A; Liu J; Zhou H
    Platelets; 2023 Dec; 34(1):2258988. PubMed ID: 37722393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose dexamethasone as an alternative rescue therapy for active bleeding in children with chronic ITP: clinical and immunological effects.
    Youssef MAM; Salah Eldeen E; Elsayh KI; Taha SF; Abo-Elela MGM
    Platelets; 2019; 30(7):886-892. PubMed ID: 30346851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.
    Borst F; Keuning JJ; van Hulsteijn H; Sinnige H; Vreugdenhil G
    Ann Hematol; 2004 Dec; 83(12):764-8. PubMed ID: 15309522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose dexamethasone modulates serum cytokine profile in patients with primary immune thrombocytopenia.
    Zhan Y; Zou S; Hua F; Li F; Ji L; Wang W; Ye Y; Sun L; Chen H; Cheng Y
    Immunol Lett; 2014 Jul; 160(1):33-38. PubMed ID: 24657323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.